Enlivex Therapeutics For Profit

Allocetra™ is an innovative immunotherapy that is being developed to rebalance life-threatening hyperactivity of the immune system, using the immune system’s own natural regulation mechanisms. By intelligently engaging macrophages and dendritic cells, Allocetra™ is designed to avert cytokine storms and restores safe immune balance – without suppressing the immune system.

Founded Date: 2005-10-01
Headquarters: Ness Ziona, HaMerkaz, Israel
Technology: Biomarker panels
Employee Number: 11-50
Industry: Clinical Data Management
Estimated Revenue: $1M to $10M
Funding Status: IPO